Amarin Corp Plc (AMRN)

[ziploc_1]

PFE could easily buy Amarin for a tiny fraction of the $43 billion it paid for Seagen, an amount, which was largely earned from recent cash earnings from Commiraty and other products.

"Pfizer's net debt of $1B does not even account for PFE’s ~$10B stake in HLN, which can be monetized at any time... Accounting for the HLN stake (on an after-tax basis), PFE has NO net debt, but rather has net cash of $5-10B."

Seagen was bought for its high priced molecules for cancer...It would be nice for Pfizer to offset this with Amarin's low priced EPA molecule for CVD